Thermo Fisher Scientific Completes CE-IVD Registration of its QuantStudio™ 5 Dx System for In Vitro Diagnostic Use in Europe

SAN DIEGO, July 31, 2017 /PRNewswire/ — AACC — Thermo Fisher Scientific today announced the successful CE-IVD registration of its QuantStudio 5 Dx Real-Time PCR System for sale in European countries. The platform provides European customers with modern and user-friendly instrument that is designed to easily integrate into their existing diagnostic workflow. The product will be on exhibit... Read more

Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017

Jul. 31, 2017 SAN DIEGO, July 31, 2017 /PRNewswire/ — AACC — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest advancements in clinical and research-based solutions during the 2017 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, being held July 31 – August 3 at the San Diego Convention Center. Among the products displayed within booth #4039 is a... Read more

First Fully Integrated LC-MS System for Clinical Diagnostics Announced by SCIEX

The SCIEX Topaz™ System lowers the barriers to adoption of LC-MS to clinical diagnostic labs by making this powerful technology accessible to all users July 31, 2017 Framingham, MA — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the launch of the first fully integrated... Read more

Latest Beckman Coulter Clinical Flow Cytometry Product Gains FDA Clearance

Workflow-Efficient Navios EX Flow Cytometer for Immunophenotyping in the Clinical Lab SAN DIEGO, CALIF. – (July 31, 2017) – Beckman Coulter Life Sciences has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest clinical flow cytometry product, the Navios EX flow cytometer, to be used in the clinical laboratory in the... Read more

New England Biolabs® and TTP plc collaborate to provide services for molecular diagnostics

New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products CAMBRIDGE, England and IPSWICH, Mass., July 28, 2017 /PRNewswire/ — TTP plc, a leading technology and product development company, and New England Biolabs, Inc. (NEB®), an industry leader in the discovery and production of enzymes for molecular biology applications, today announce... Read more

Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China

SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop molecular diagnostics in China. Under the terms of the partnership, Ascendas Genomics will develop and commercialize molecular diagnostic systems and assays in China using microfluidic technologies included in the Fluidigm® Biomark™ HD and Juno™ systems. Fluidigm’s microfluidic technology enables... Read more

Unique concept of MDx, Seegene Random Access System, announced at AACC 2017

Seoul, South Korea – July 26, 2017 – Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the “System”) at the 69th AACC Annual Clinical Lab Expo in San Diego, CA, from July 30 to August 3. The ‘Seegene Random Access... Read more

Agilent Technologies Introduces Real-Time PCR System for Clinical Diagnostics in Europe

AriaDx Provides Modular Solution for Diagnostic Labs and Assay Developers SANTA CLARA, Calif., July 25, 2017 Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic... Read more